Mesirow Financial Investment Management - Fixed Income’s United Therapeutics UTHR Stock Holding History

Mesirow Financial Investment Management - Fixed Income’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-14,425	Closed	-$3.12M	–	148
2021 Q4	$3.12M	Buy	14,425 +1,135	+9%	+$223K	0.34%	86
2021 Q3	$2.45M	Buy	13,290 +1,060	+9%	+$209K	0.28%	90
2021 Q2	$2.19M	Sell	12,230 -44,235	-78%	-$8.42M	0.25%	103
2021 Q1	$9.45M	Sell	56,465 -6,730	-11%	-$1.12M	1.1%	27
2020 Q4	$9.59M	Sell	63,195 -710	-1%	-$93.2K	1.28%	8
2020 Q3	$6.45M	Buy	63,905 +6,245	+11%	+$685K	1.1%	27
2020 Q2	$6.98M	Buy	57,660 +17,800	+45%	+$2M	1.27%	21
2020 Q1	$3.78M	Buy	+39,860	New	+$3.79M	0.9%	56

Other funds holding UTHR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Mesirow Financial Investment Management - Fixed Income's UTHR Position: Q1 2022 in Review

Mesirow Financial Investment Management - Fixed Income sold out of United Therapeutics (UTHR) in Q1 2022, closing a stake of 14,425 shares — an estimated $3.12M sold.

Mesirow Financial Investment Management - Fixed Income first reported a position in UTHR in Q1 2020 and held it in 8 quarters. The position peaked at $9.59M in Q4 2020. 428 funds tracked by Wall St. Rank hold UTHR as of Q1 2022.

Mesirow Financial Investment Management - Fixed Income reported no remaining United Therapeutics position as of Q1 2022 after selling out during the quarter.
Mesirow Financial Investment Management - Fixed Income sold 14,425 United Therapeutics shares in Q1 2022, an estimated $3.12M.
Mesirow Financial Investment Management - Fixed Income first reported a position in United Therapeutics in Q1 2020 and held it in 8 quarters.
Mesirow Financial Investment Management - Fixed Income's United Therapeutics position peaked at $9.59M in Q4 2020.
428 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2022.

Based on Mesirow Financial Investment Management - Fixed Income's 13F filing for Q1 2022, filed 9 May 2022.